Management of Traumatic Hyphema in Children

Ultrasonographic abnormalities in eyes with traumatic hyphema obscuring intraocular structures: 33 cases (1991–2002)

“…In humans, systemically administered aminocaproic acid significantly reduces the incidence of recurrent hemorrhaging. However, aminocaproic acid is not often prescribed due to its expense, regimen of administration, and side effects including nausea, vomiting, and systemic hypotension 20–22 . Therapy to induce mydriasis inhibits the formation of posterior synechiae but may also acutely increase intraocular pressure 8,23 …”

Ultrasonographic abnormalities in eyes with traumatic hyphema obscuring intraocular structures: 33 cases (1991–2002)

“…In humans, systemically administered aminocaproic acid significantly reduces the incidence of recurrent hemorrhaging. However, aminocaproic acid is not often prescribed due to its expense, regimen of administration, and side effects including nausea, vomiting, and systemic hypotension 20–22 . Therapy to induce mydriasis inhibits the formation of posterior synechiae but may also acutely increase intraocular pressure 8,23 …”

Ultrasonographic abnormalities in eyes with traumatic hyphema obscuring intraocular structures: 33 cases (1991–2002)

“…In humans, systemically administered aminocaproic acid significantly reduces the incidence of recurrent hemorrhaging. However, aminocaproic acid is not often prescribed due to its expense, regimen of administration, and side effects including nausea, vomiting, and systemic hypotension 20–22 . Therapy to induce mydriasis inhibits the formation of posterior synechiae but may also acutely increase intraocular pressure 8,23 …”

Ultrasonographic abnormalities in eyes with traumatic hyphema obscuring intraocular structures: 33 cases (1991–2002)

“…In humans, systemically administered aminocaproic acid significantly reduces the incidence of recurrent hemorrhaging. However, aminocaproic acid is not often prescribed due to its expense, regimen of administration, and side effects including nausea, vomiting, and systemic hypotension 20–22 . Therapy to induce mydriasis inhibits the formation of posterior synechiae but may also acutely increase intraocular pressure 8,23 …”